Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

697 public trials 122 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

NCT00448357

Conditions: Blast Crisis, Blood Coagulation Disorders, Blood Platelet Disorders, +72 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

NCT00607997

Conditions: Acute Disease, Acute Myeloid Leukemia, Bone Marrow Diseases, +12 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Scripps Cancer Center La Jolla, California, United States

Rocky Mountain Blood and Marrow Transplant Program Denver, Colorado, United States

View all 20 locations

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

NCT00691015

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +57 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS

NCT00744536

Conditions: Angiogenesis, Bone Marrow Diseases, Chronic Disease, +12 more
Locations: Sunnybrook Health Sciences Centre, Odette Cancer Center Toronto, Ontario, Canada

View Trial Details

Completed

Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies

NCT00241358

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

NCT01158118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +31 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload

NCT00481143

Conditions: Anemia, Anemia, Refractory, Bone Marrow Diseases, +8 more
Locations: Novartis Investigative Site Berlin, Germany

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

NCT00513474

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions